ResMed Inc (RMD)
231.43
-4.01
(-1.70%)
USD |
NYSE |
Nov 14, 16:00
232.99
+1.56
(+0.67%)
Pre-Market: 05:43
ResMed Free Cash Flow (Quarterly): 305.93M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 305.93M |
| June 30, 2024 | 413.79M |
| March 31, 2024 | 378.92M |
| December 31, 2023 | 248.27M |
| September 30, 2023 | 245.42M |
| June 30, 2023 | 198.70M |
| March 31, 2023 | 251.34M |
| December 31, 2022 | 96.97M |
| September 30, 2022 | 12.29M |
| June 30, 2022 | 47.09M |
| March 31, 2022 | 65.28M |
| December 31, 2021 | 180.19M |
| September 30, 2021 | -97.45M |
| June 30, 2021 | 195.65M |
| March 31, 2021 | 167.13M |
| December 31, 2020 | 131.84M |
| September 30, 2020 | 125.26M |
| June 30, 2020 | 309.08M |
| March 31, 2020 | 207.59M |
| December 31, 2019 | 42.03M |
| September 30, 2019 | 137.62M |
| June 30, 2019 | 117.54M |
| March 31, 2019 | 122.65M |
| December 31, 2018 | 109.00M |
| September 30, 2018 | 32.51M |
| Date | Value |
|---|---|
| June 30, 2018 | 109.66M |
| March 31, 2018 | 134.00M |
| December 31, 2017 | 114.20M |
| September 30, 2017 | 75.71M |
| June 30, 2017 | 119.67M |
| March 31, 2017 | 50.61M |
| December 31, 2016 | 103.08M |
| September 30, 2016 | 69.21M |
| June 30, 2016 | 126.16M |
| March 31, 2016 | 109.56M |
| December 31, 2015 | 138.60M |
| September 30, 2015 | 105.78M |
| June 30, 2015 | 85.13M |
| March 31, 2015 | 78.05M |
| December 31, 2014 | 84.56M |
| September 30, 2014 | 63.49M |
| June 30, 2014 | 94.33M |
| March 31, 2014 | 80.96M |
| December 31, 2013 | 62.83M |
| September 30, 2013 | 71.99M |
| June 30, 2013 | 105.57M |
| March 31, 2013 | 86.01M |
| December 31, 2012 | 76.08M |
| September 30, 2012 | 63.39M |
| June 30, 2012 | 83.44M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-97.45M
Minimum
Sep 2021
413.79M
Maximum
Jun 2024
176.27M
Average
187.92M
Median
Free Cash Flow (Quarterly) Benchmarks
| Boston Scientific Corp | 698.00M |
| Globus Medical Inc | 161.70M |
| Abbott Laboratories | 2.149B |
| Becton Dickinson & Co | 883.00M |
| Integra Lifesciences Holdings Corp | -7.161M |